Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine for Coronary Plaque Stability in ACS
NCT04848857Phase 4Completed
- Start
- May 2021
- Primary completion
- Aug 2023
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of colchicine in acute coronary syndrome (ACS). Started May 2021; status: completed.
02
Drugs
colchicine
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT04848857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04848857.